Skip to main content
BoomMag: Readers and Fans
Advertise With Us Newsletter

WLT Report WLT Report

Advertise With Us Newsletter
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

FLASHBACK: Box of Mosquitoes Vaccinated Subjects In Malaria Trial

WLTReport relayed reports of the first “locally-acquired” malaria cases in the United States in twenty years.

Four malaria cases were found in Florida and one in Texas.

The state of Florida this week issued a statewide malaria alert.

Florida Issues Statewide Alert

However, we’ve asked a legitimate question about these sudden malaria cases in Florida and Texas.

Is Bill Gates to blame?

Bill Gates-funded Oxitec released genetically-modified mosquitoes in Florida and Texas.

Even Snopes admits it.

ADVERTISEMENT

From Snopes:

Bill Gates is not himself releasing mosquitoes into the wild. However, the Bill and Melinda Gates Foundation did award grants that funded biotech company Oxitec’s work to develop genetically modified mosquitoes that may help reduce the spread of malaria and other mosquito-borne diseases in certain locations around the world. In April 2021, it was announced that Oxitec would release approximately 150,000 mosquitoes across six locations in Florida. However, the company told Snopes that this particular project was not funded by the Bill and Melinda Gates Foundation.

A multi-year research project to genetically modify Aedes aegypti, a mosquito species that is known to carry and transmit infectious diseases to humans, was slated to move from the lab to the fields of Texas and Florida in mid-2021. Under the project, thousands of A. aegypti were altered to make their reproduction more difficult, thus slowing and eventually preventing the spread of mosquito-borne illnesses like Zika, and dengue fever. But when the internet caught wind that Bill Gates may have been behind the project, posts circulated on social media that questioned the real motivation behind the project.

Let’s dig a little deeper into this malaria craze.

Labiotech has more on the Bill Gates-funded Oxitec biotech company.

The Bill & Melinda Gates Foundation has partnered with Oxitec for the development of a new strain of genetically-modified mosquitoes that can help reduce the spread of malaria in America.

In its latest effort to free the world of malaria, the Bill & Melinda Gates Foundation has joined forces with Oxitec, a British company that genetically engineers insects to fight the spread of diseases such as Zika, dengue or chikungunya, as well as to protect crops from plagues.

Oxitec has developed a self-limiting technology that selects against female mosquitoes — the ones who bite and spread disease. When male mosquitoes carrying Oxitec’s self-limiting gene are released, they mate with wild females. The females of their offspring will die before adulthood, while the surviving males can mate again with wild females. The self-limiting gene can survive for up to ten generations, after which no genetically-modified mosquitoes remain.

ADVERTISEMENT

The U.S. Environmental Protection Agency gave the green light for Bill Gates and Oxitec to release their GMO mosquitoes in the United States.

First Coast News presented this report in 2022:

In fact, Bill Gates is releasing GMO mosquitoes in multiple countries.

The world’s largest mosquito factory, located in Medellin, Colombia, produces 30 million GMO mosquitoes per week.

WATCH:

https://twitter.com/flugkind/status/1671018834562633728?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1671018834562633728%7Ctwgr%5E99c23c1079356bc82e4143a1503b2354f5e731f2%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Fwltreport.com%2F2023%2F06%2F29%2Fflorida-issues-statewide-alert%2F

Bill Gates wrote a piece on Medellin’s mosquito factory in 2022:

Inside a two-story brick building in Medellín, Colombia, scientists work long hours in muggy labs breeding millions and millions of mosquitoes. They tend to the insects’ every need as they grow from larvae to pupae to adults, keeping the temperature just right and feeding them generous helpings of fishmeal, sugar, and, of course, blood.

ADVERTISEMENT

Then, they release them across the country to breed with wild mosquitoes that can carry dengue and other viruses threatening to sicken and kill the population of Colombia.

This might sound the beginnings of a Hollywood writer’s horror film plot.

But it’s not.

This factory is real.

And the mosquitoes being released don’t terrorize the local population. Far from it. They’re actually helping to save and improve millions of lives.

If you’re guessing they have a malaria vaccine in development, you’d be correct.

And it’s another extremely dangerous shot.

From the Bill & Melinda Gates Foundation:

Bill Gates announced today that the Bill & Melinda Gates Foundation will provide $168.7 million to PATH for its Malaria Vaccine Initiative to develop vaccines for malaria – a disease that kills thousands of African children every day.

The PATH Malaria Vaccine Initiative (MVI) is working with GlaxoSmithKline Biologicals to develop a first-generation vaccine candidate, known as RTS,S, which could become the first-ever approved malaria vaccine. With the new grant announced today, MVI will support the development of next-generation vaccines that could provide even greater and longer-lasting protection.

ADVERTISEMENT

“I’m very hopeful that the malaria vaccine currently in advanced testing will be proven effective, but that will just be the first step,” said Gates, co-chair of the Gates Foundation. “Now it’s time to develop a new generation of vaccines that are even more effective, and could someday help eradicate malaria altogether.”

Gates announced the new funding at the UN Millennium Development Goals Malaria Summit, a meeting of heads of state, CEOs, UN officials, and other leaders. At the event, the Roll Back Malaria Partnership launched the Global Malaria Action Plan, a comprehensive global strategy to fight malaria. The Gates Foundation grant and other commitments announced today will help address key priorities in the Action Plan.

The RTS,S malaria vaccine is currently being tested in Africa.

The WHO announced its recommendation of the shot:

The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. The recommendation is based on results from an ongoing pilot programme in Ghana, Kenya and Malawi that has reached more than 900 000 children since 2019.

“This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control,” said WHO Director-General Dr Tedros Adhanom Ghebreyesus. “Using this vaccine on top of existing tools to prevent malaria could save tens of thousands of young lives each year.”

Malaria remains a primary cause of childhood illness and death in sub-Saharan Africa. More than 260 000 African children under the age of five die from malaria annually.

In recent years, WHO and its partners have been reporting a stagnation in progress against the deadly disease.

“For centuries, malaria has stalked sub-Saharan Africa, causing immense personal suffering,” said Dr Matshidiso Moeti, WHO Regional Director for Africa. “We have long hoped for an effective malaria vaccine and now for the first time ever, we have such a vaccine recommended for widespread use. Today’s recommendation offers a glimmer of hope for the continent which shoulders the heaviest burden of the disease and we expect many more African children to be protected from malaria and grow into healthy adults.”

WHO recommendation for the RTS,S malaria vaccine

Based on the advice of two WHO global advisory bodies, one for immunization and the other for malaria, the Organization recommends that:

WHO recommends that in the context of comprehensive malaria control the RTS,S/AS01 malaria vaccine be used for the prevention of P. falciparum malaria in children living in regions with moderate to high transmission as defined by WHO. RTS,S/AS01 malaria vaccine should be provided in a schedule of 4 doses in children from 5 months of age for the reduction of malaria disease and burden.

“The Bill & Melinda Gates Foundation provided catalytic funding for late-stage development of RTS,S between 2001 and 2015,” the WHO stated.

WATCH:

However, a team of researchers disputed the WHO’s findings in a paper published in in The Lancet Infectious Diseases.

The researchers concluded that the findings in the malaria vaccine implementation programme (MVIP) “do not rule out the possibility of increased mortality among vaccinated girls compared with vaccinated boys, as observed in the phase 3 studies.”

“Three significant safety signals were identified, related to meningitis, cerebral malaria, and female-specific all-cause mortality,” the researchers noted.

The researchers concluded that the “claimed impact of the MVIP on mortality is not based on enough scientific evidence.”

The vaccine’s impact on severe malaria was estimated to be around 30%.

The paper’s final conclusions stated:

We have made several recommendations for the way forward (panel). Populations affected by malaria and their policy makers have waited for a vaccine for about half a century. The enthusiasm greeting the WHO recommendation of RTS,S is understandable. Unfortu-nately, the available data suggest that this vaccine, like some other non-live vaccines,16, 17 might increase all-cause mortality in girls to the extent that its deployment could lead to a net increase in deaths of girls among the recipients.

UPDATE

.

.

.

There’s another legitimate question we have to ask regarding these malaria developments.

Are they attempting to genetically modify mosquitoes to vaccinate people for malaria?

Is this technology in development?

Is this technology already here?

Mosquitoes vaccinating humans.

It may sound like a conspiracy theory, but the mainstream media reported on this Frankenstein experiment.

NPR published a piece in 2022 titled, “A box of 200 mosquitoes did the vaccinating in this malaria trial. That’s not a joke!”

From NPR:

One Seattle morning, Carolina Reid sat in a room with nine other volunteers, each waiting to take part in a clinical trial for a new, experimental malaria vaccine.

Reid’s turn came. She put her arm over a cardboard box filled with 200 mosquitoes and covered with a mesh that keeps them in but still lets them bite. “Literally a Chinese food takeout container” is how she remembers it. A scientist then covered her arm with a black cloth, because mosquitoes like to bite at night.

Then the feeding frenzy began.

“My whole forearm swelled and blistered,” says Reid. “My family was laughing, asking like, ‘why are you subjecting yourself to this?'” And she didn’t just do it once. She did it five times.

You may be thinking – this is a joke, right?

But it’s not. “We use the mosquitoes like they’re 1,000 small flying syringes,” explains University of Washington, Seattle physician and scientist Dr. Sean Murphy, lead author on a paper in Science Translational Medicine released on August 24 detailing the vaccine trials.

The insects deliver live malaria-causing Plasmodium parasites that have been genetically modified to not get people sick. The body still makes antibodies against the weakened parasite so it’s prepared to fight the real thing.

To be clear, Murphy’s not planning to use mosquitoes to vaccinate millions of people. Mosquitoes have been used to deliver malaria vaccines for clinical trials in the past, but it’s not common.

He and his colleagues went this route because it is costly and time consuming to develop a formulation of a parasite that can be delivered with a needle. The parasites mature inside mosquitoes so at this proof of concept stage – as early stage trials are called — it makes sense to use them for delivery.

“They went old school with this one,” says Dr. Kirsten Lyke, a physician and vaccine researcher at the University of Maryland School of Medicine who was not involved in the study. “All things old become new again.”

She calls the use of a genetically modified live parasite “a total game changer” for vaccine development.

This type of vaccine is of course not yet ready for prime time. But the small trial of 26 participants did show that the modified parasites protected some participants from a malaria infection for a few months.


, ,

 

Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

log in

Forgot password?

reset password

Back to
log in
Leave a comment
Thanks for sharing!
Thanks for sharing!
We invite you to become a WLT Report insider. Sign up for our free email newsletter, and we'll make sure to keep you in the loop.